BRIEF published on 10/01/2024 at 13:41, 1 year 11 months ago Novacyt Provides Monthly Update on Liquidity Agreement and Total Voting Rights Shareholders Voting Rights Liquidity Agreement INVEST SECURITIES Novacyt
PRESS RELEASE published on 10/01/2024 at 13:36, 1 year 11 months ago Liquidity Agreement Monthly Update and Total Voting Rights Novacyt provides a monthly update on its liquidity agreement with Invest Securities SA and discloses total voting rights. The agreement involves purchasing and selling ordinary shares under French law Liquidity Agreement Total Voting Rights French Law Novacyt Invest Securities SA
BRIEF published on 09/17/2024 at 10:27, 1 year 11 months ago Novacyt Announces HY 2024 Results and Investor Webinar Financial Results Investor Presentation Webinar Diagnostics Novacyt
PRESS RELEASE published on 09/17/2024 at 10:26, 1 year 11 months ago Launch of new website Novacyt S.A. announces the launch of its new website which better reflects the expanded Group following the acquisition of Yourgene Health. Visit novacyt.com for more information Intégration Molecular Diagnostics New Website Novacyt S.A. Yourgene Health
PRESS RELEASE published on 09/17/2024 at 10:22, 1 year 11 months ago Notice of Half Year 2024 Results and Investor Presentation Novacyt S.A. to report half year 2024 results on 26 Sep 2024. Investor webinar scheduled. Novacyt is an international molecular diagnostics company with diverse technologies and services Financial Presentation Half Year Results Molecular Diagnostics Investor Webinar Novacyt S.A.
BRIEF published on 09/06/2024 at 11:51, 2 years ago Novacyt: Monthly Review of the Liquidity and Voting Rights Agreement Common Shares Voting Rights Liquidity Contract INVEST SECURITIES Novacyt
BRIEF published on 08/22/2024 at 12:52, 2 years ago Successful VAT recovery for Novacyt Financial Health Regulation Novacyt VAT Recovered DHSC Dispute
BRIEF published on 08/22/2024 at 12:49, 2 years ago Successful VAT reclaim of £12.2 million by Novacyt Financial Settlement Diagnostics Novacyt VAT Reclaim HMRC
PRESS RELEASE published on 08/22/2024 at 12:44, 2 years ago Successful VAT reclaim of £12.2 million Novacyt successfully reclaims £12.2 million in VAT from HMRC, increasing net cash position by over £7.0 million. Inside information disclosed Inside Information Novacyt VAT Reclaim Net Cash Position HMRC
BRIEF published on 07/25/2024 at 12:32, 2 years 1 month ago Novacyt publishes its unaudited half-yearly activity report Acquisition R&D Turnover Novacyt Semestrial Report
Published on 09/16/2026 at 23:45, 5 hours 3 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 7 hours 18 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 11 hours 53 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 13 hours 48 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 14 hours 48 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/17/2026 at 04:25, 22 minutes ago Zhou Jianjun from Huawei: Building a Grid-Interactive AIDC Solution to Maximize Tokens Per Watt
Published on 09/16/2026 at 23:45, 5 hours 2 minutes ago WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 6 hours 14 minutes ago EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 7 hours 32 minutes ago Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 8 hours 20 minutes ago EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 17:45, 11 hours 3 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 21 hours 48 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 10 hours ago Report on the Combined General Meeting of the 10th of September 2026
